Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

2.

PSMA PET Beats MRI in Prostate Cancer Staging Study

3.

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic

4.

Using AI, one can find cancer risk factors.

5.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot